About the Conference

The 31st World Conference on Gastroenterology & Hepatology will take place on July 28-29, 2025, in Dubai, UAE, under the theme “Emerging Trends in Hepatology: Liver Disease, Cirrhosis, and Transplantation.” This international event will bring together leading gastroenterologists, hepatologists, researchers, clinicians, and industry experts to discuss the latest advancements in liver and digestive health.

This conference serves as a global platform for knowledge exchange, scientific discussions, and professional networking. It will feature plenary sessions, keynote presentations, panel discussions, workshops, symposiums, and poster sessions, focusing on cutting-edge research in hepatology, liver disease management, cirrhosis treatment, transplantation, and gastrointestinal disorders. Experts will share insights into the latest therapeutic approaches, diagnostic advancements, and innovations shaping the future of digestive health.

Participants will have the opportunity to engage with world-renowned speakers, collaborate with peers, and explore new research directions. The conference fosters interdisciplinary partnerships, encouraging dialogue between academia, healthcare professionals, and industry leaders.

Join us in Dubai, a global hub for science and innovation, to stay at the forefront of gastroenterology and hepatology advancements. Don’t miss this opportunity to contribute to the future of liver and digestive health!

Why Attend?

The 31st World Conference on Gastroenterology & Hepatology offers a unique opportunity to engage with global experts and stay at the forefront of advancements in digestive and liver health. Here’s why you should attend:

1. Cutting-Edge Research & Insights

Gain exclusive access to the latest breakthroughs in hepatology, liver disease management, cirrhosis, transplantation, and gastrointestinal disorders through keynote speeches, plenary talks, and research presentations by leading experts.

2. Interactive Learning & Skill Development

Enhance your knowledge with workshops, symposiums, and panel discussions, covering innovative diagnostic techniques, therapeutic approaches, and AI-driven advancements in gastroenterology.

3. Networking with Global Experts

Connect with renowned hepatologists, gastroenterologists, researchers, clinicians, and industry professionals from around the world. Foster collaborations, exchange ideas, and expand your professional network.

4. Career Growth & Research Opportunities

Stay ahead in your field with insights into emerging technologies, clinical trials, and future research directions that can shape your career and scientific contributions.

5. Experience Dubai – A Global Scientific Hub

Attend this world-class conference in Dubai, a dynamic city offering a blend of innovation, culture, and luxury—making your participation both professionally and personally rewarding.

Don’t miss the chance to be part of this transformative event. Register now to shape the future of gastroenterology and hepatology!

Who Can Attend?

• Gastroenterologists

• Hepatologists

• GI & Hepatobiliary Surgeons

• Endoscopists

• Liver Transplant Physicians & Surgeons

• Researchers & Scientists in Gastroenterology & Hepatology

• GI Pathologists & Radiologists

• Fellows, Residents & Medical Students in GI & Hepatology

Market Analysis

The global gastroenterology and hepatology market is experiencing significant growth, driven by rising cases of liver diseases, digestive disorders, and gastrointestinal cancers. The increasing prevalence of non-alcoholic fatty liver disease (NAFLD), cirrhosis, and hepatocellular carcinoma (HCC) has fueled demand for advanced diagnostics, endoscopic procedures, and liver transplantation services.

The market is expected to reach $65 billion by 2025, with a CAGR of 5.8%, supported by innovations in biologics, microbiome research, artificial intelligence (AI) in diagnostics, and precision medicine. The Asia-Pacific region is projected to witness the fastest growth due to increasing healthcare investment and a rising burden of liver diseases.

Key drivers include technological advancements in endoscopy, AI-assisted diagnostics, increasing R&D investments, and government initiatives. The industry is also witnessing a surge in drug development for inflammatory bowel disease (IBD), hepatitis, and metabolic liver disorders.